Literature DB >> 21571930

Bacillus iranensis sp. nov., a moderate halophile from a hypersaline lake.

M Bagheri1,2, M Didari2, M A Amoozegar1, P Schumann3, C Sánchez-Porro4, M Mehrshad2, A Ventosa4.   

Abstract

A Gram-positive, moderately halophilic rod, designated X5BT, was isolated from saline mud of the hypersaline lake Aran-Bidgol in Iran. Strain X5BT was a strictly aerobic, motile bacterium that produced ellipsoidal endospores at a central-subterminal position in non-swollen sporangia. The isolate grew at pH 7.0-10.0 (optimum pH 7.5), at 25-45 °C (optimum 35 °C) and with 2.5-15 % (w/v) NaCl (optimum 5-7.5 %). On the basis of 16S rRNA gene sequences, strain X5BT belonged to the genus Bacillus and showed highest similarity with Bacillus persepolensis HS136T (95.6 % 16S rRNA gene sequence similarity) and Bacillus salarius BH169T (95.5 %). The DNA G+C content was 42.4 mol%. The major cellular fatty acids were anteiso-C15:0 and iso-C15:0 and the polar lipid profile consisted of phosphatidylglycerol, diphosphatidylglycerol, three phospholipids and two glycolipids. The diamino acid found in the cell-wall peptidoglycan was meso-diaminopimelic acid and the isoprenoid quinones were MK-7 (92 %), MK-6 (6 %) and MK-5 (2 %). On the basis of phylogenetic, chemotaxonomic and phenotypic data, a novel species of the genus Bacillus is proposed, with the name Bacillus iranensis sp. nov. The type strain is X5BT (=IBRC 10446T=DSM 23995T).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571930     DOI: 10.1099/ijs.0.030874-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  1 in total

1.  A comparative GC-MS analysis of bioactive secondary metabolites produced by halotolerant Bacillus spp. isolated from the Great Sebkha of Oran.

Authors:  Fatima Nas; Nadia Aissaoui; Mouna Mahjoubi; Amor Mosbah; Mounia Arab; Soukaina Abdelwahed; Rim Khrouf; Ahmed-Salaheddine Masmoudi; Ameur Cherif; Nihel Klouche-Khelil
Journal:  Int Microbiol       Date:  2021-06-07       Impact factor: 2.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.